Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EIF4A1P1 is a pseudogene—an inactive genetic segment that arose from the Eukaryotic translation initiation factor 4A1 (EIF4A1) gene[3]. Unlike its parental gene EIF4A1, which encodes a DEAD-box RNA helicase crucial for unwinding mRNA during ribosome recruitment and translation initiation[1][5], the pseudogene does not produce a functional protein and has no known biological or pathological functions. Although some pseudogenes can occasionally play regulatory roles via non-coding RNA-mediated mechanisms[4], there is no evidence that EIF4A1P1 has such a function. It is not considered a therapeutic target, nor is it used in biomarker assays or known to interact with any drugs[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4A1 pseudogene 1 (EIF4A1P1).